{"pmid":32386057,"title":"3D-Printing to Address COVID-19 Testing Supply Shortages.","text":["3D-Printing to Address COVID-19 Testing Supply Shortages.","The recent SARS-CoV-2 outbreak has placed immense pressure on supply chains, including shortages in nasopharyngeal (NP) swabs. Here, we report our experience of using 3D-printing to rapidly develop and deploy custom-made NP swabs to address supply shortages at our healthcare institution.","Lab Med","Cox, Jesse L","Koepsell, Scott A","32386057"],"abstract":["The recent SARS-CoV-2 outbreak has placed immense pressure on supply chains, including shortages in nasopharyngeal (NP) swabs. Here, we report our experience of using 3D-printing to rapidly develop and deploy custom-made NP swabs to address supply shortages at our healthcare institution."],"journal":"Lab Med","authors":["Cox, Jesse L","Koepsell, Scott A"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386057","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/labmed/lmaa031","keywords":["3d-printing","covid","np swab","irology","linical pathology","molecular diagnostics"],"topics":["Prevention"],"weight":1,"_version_":1666340102036520960,"score":9.490897,"similar":[{"pmid":32393482,"title":"Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.","text":["Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.","The SARS-CoV-2 pandemic has caused a severe international shortage of the nasopharyngeal swabs that are required for collection of optimal specimens, creating a critical bottleneck blocking clinical laboratories' ability to perform high-sensitivity virological testing for SARS-CoV-2. To address this crisis, we designed and executed an innovative, cooperative, rapid-response translational-research program that brought together healthcare workers, manufacturers, and scientists to emergently develop and clinically validate new swabs for immediate mass production by 3D printing. We performed a multi-step preclinical evaluation on 160 swab designs and 48 materials from 24 companies, laboratories, and individuals, and shared results and other feedback via a public data repository (http://github.com/rarnaout/Covidswab/) We validated four prototypes through an institutional review board (IRB)-approved clinical trial that involved 276 outpatient volunteers who presented to our hospital's drive-through testing center with symptoms suspicious for COVID-19. Each participant was swabbed with a reference swab (the control) and a prototype, and SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR) results were compared. All prototypes displayed excellent concordance with the control (kappa=0.85-0.89). Cycle-threshold (Ct) values were not significantly different between each prototype and the control, supporting the new swabs' non-inferiority (Mann-Whitney U [MWU] p>0.05). Study staff preferred one of the prototypes over the others and the control swab overall. The total time elapsed between identification of the problem and validation of the first prototype was 22 days. Contact information for ordering can be found at http://printedswabs.org Our experience holds lessons for the rapid development, validation, and deployment of new technology for this pandemic and beyond.","J Clin Microbiol","Callahan, Cody J","Lee, Rose","Zulauf, Katelyn E","Tamburello, Lauren","Smith, Kenneth P","Previtera, Joe","Cheng, Annie","Green, Alex","Azim, Ahmed Abdul","Yano, Amanda","Doraiswami, Nancy","Kirby, James E","Arnaout, Ramy A","32393482"],"abstract":["The SARS-CoV-2 pandemic has caused a severe international shortage of the nasopharyngeal swabs that are required for collection of optimal specimens, creating a critical bottleneck blocking clinical laboratories' ability to perform high-sensitivity virological testing for SARS-CoV-2. To address this crisis, we designed and executed an innovative, cooperative, rapid-response translational-research program that brought together healthcare workers, manufacturers, and scientists to emergently develop and clinically validate new swabs for immediate mass production by 3D printing. We performed a multi-step preclinical evaluation on 160 swab designs and 48 materials from 24 companies, laboratories, and individuals, and shared results and other feedback via a public data repository (http://github.com/rarnaout/Covidswab/) We validated four prototypes through an institutional review board (IRB)-approved clinical trial that involved 276 outpatient volunteers who presented to our hospital's drive-through testing center with symptoms suspicious for COVID-19. Each participant was swabbed with a reference swab (the control) and a prototype, and SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR) results were compared. All prototypes displayed excellent concordance with the control (kappa=0.85-0.89). Cycle-threshold (Ct) values were not significantly different between each prototype and the control, supporting the new swabs' non-inferiority (Mann-Whitney U [MWU] p>0.05). Study staff preferred one of the prototypes over the others and the control swab overall. The total time elapsed between identification of the problem and validation of the first prototype was 22 days. Contact information for ordering can be found at http://printedswabs.org Our experience holds lessons for the rapid development, validation, and deployment of new technology for this pandemic and beyond."],"journal":"J Clin Microbiol","authors":["Callahan, Cody J","Lee, Rose","Zulauf, Katelyn E","Tamburello, Lauren","Smith, Kenneth P","Previtera, Joe","Cheng, Annie","Green, Alex","Azim, Ahmed Abdul","Yano, Amanda","Doraiswami, Nancy","Kirby, James E","Arnaout, Ramy A"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32393482","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1128/JCM.00876-20","locations":["swab"],"topics":["Diagnosis"],"weight":1,"_version_":1666627827985809408,"score":174.24687},{"pmid":32425660,"pmcid":"PMC7228872","title":"A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.","text":["A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.","Given the global shortage of nasopharyngeal (NP) swabs typically used for respiratory virus detection, alternative collection methods were evaluated during the COVID-19 pandemic. This study showed that a combined oropharyngeal/nares swab is a suitable alternative to NP swabs for the detection of SARS-CoV-2, with sensitivities of 91.7% and 94.4%, respectively.","J Clin Virol","LeBlanc, Jason J","Heinstein, Charles","MacDonald, Jimmy","Pettipas, Janice","Hatchette, Todd F","Patriquin, Glenn","32425660"],"abstract":["Given the global shortage of nasopharyngeal (NP) swabs typically used for respiratory virus detection, alternative collection methods were evaluated during the COVID-19 pandemic. This study showed that a combined oropharyngeal/nares swab is a suitable alternative to NP swabs for the detection of SARS-CoV-2, with sensitivities of 91.7% and 94.4%, respectively."],"journal":"J Clin Virol","authors":["LeBlanc, Jason J","Heinstein, Charles","MacDonald, Jimmy","Pettipas, Janice","Hatchette, Todd F","Patriquin, Glenn"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425660","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jcv.2020.104442","keywords":["covid-19","pcr","sars-cov-2","nares","oropharyngeal","swab"],"topics":["Diagnosis"],"weight":1,"_version_":1667352728794300416,"score":170.87685},{"pmid":32337516,"title":"Use of free CAD design software for 3D printing individualized face masks based on face scans.","text":["Use of free CAD design software for 3D printing individualized face masks based on face scans.","AIM: To describe a method of digitally customizing 3D-printed face mask designs using 3D face scans and free software. MATERIALS AND METHODS: The procedure of creating customized face masks initially involved importing and aligning STL files of face scans and mask components in free CAD software. The imported mask described in this article is composed of three different STL files (body, filter structure, and grid). The body of the mask was then edited to fit precisely into the face scan STL by using the software's offset tool, followed by adjustments and smoothening of the surfaces of the edges. The resulting customized body of the mask plus the filter and grid STL files were exported and 3D printed with polylactic acid (PLA) filament using a fused deposition modeling (FDM) 3D printer. For the purposes of comparison, a conventional 3D-printed mask (from the original STL files, without being customized for the face scan) was also 3D printed from the original STL files. Both face masks were tested on the same two volunteers. RESULTS: The customized 3D-printed face mask presented a higher adaptation compared with the conventional face mask. The area of facial contact matched the one digitally designed in the software. The 3D-printed grid could clip exactly into the filter, which in turn could be precisely screwed into the body of the face mask. CONCLUSION: Within the limitations of this technical report, the present findings suggest that customized 3D-printed face masks with enhanced adaptation can be digitally designed using face scans and free CAD software.","Int J Comput Dent","Cortes, Arthur Rodriguez Gonzalez","Galea, Kurt","No-Cortes, Juliana","Sammut, Edward J","Alzoubi, Emad Eddin","Attard, Nikolai J","32337516"],"abstract":["AIM: To describe a method of digitally customizing 3D-printed face mask designs using 3D face scans and free software. MATERIALS AND METHODS: The procedure of creating customized face masks initially involved importing and aligning STL files of face scans and mask components in free CAD software. The imported mask described in this article is composed of three different STL files (body, filter structure, and grid). The body of the mask was then edited to fit precisely into the face scan STL by using the software's offset tool, followed by adjustments and smoothening of the surfaces of the edges. The resulting customized body of the mask plus the filter and grid STL files were exported and 3D printed with polylactic acid (PLA) filament using a fused deposition modeling (FDM) 3D printer. For the purposes of comparison, a conventional 3D-printed mask (from the original STL files, without being customized for the face scan) was also 3D printed from the original STL files. Both face masks were tested on the same two volunteers. RESULTS: The customized 3D-printed face mask presented a higher adaptation compared with the conventional face mask. The area of facial contact matched the one digitally designed in the software. The 3D-printed grid could clip exactly into the filter, which in turn could be precisely screwed into the body of the face mask. CONCLUSION: Within the limitations of this technical report, the present findings suggest that customized 3D-printed face masks with enhanced adaptation can be digitally designed using face scans and free CAD software."],"journal":"Int J Comput Dent","authors":["Cortes, Arthur Rodriguez Gonzalez","Galea, Kurt","No-Cortes, Juliana","Sammut, Edward J","Alzoubi, Emad Eddin","Attard, Nikolai J"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337516","source":"PubMed","week":"202018|Apr 27 - May 03","keywords":["3d printing","cad/cam","covid-19","face mask","facial scanning"],"e_drugs":["poly(lactide)"],"topics":["Prevention"],"weight":1,"_version_":1666138494318149633,"score":150.70366},{"pmid":32441380,"title":"Nonserologic test for COVID-19: How to manage?","text":["Nonserologic test for COVID-19: How to manage?","BACKGROUND: Diagnosis of Severe Acute Respiratory Coranavirus-2 (SARS-CoV-2) infection is currently based on real-time PCR (RT-PCR) performed on either nasopharyngeal (NPS) or oropharyngeal (OPS) swabs; saliva specimen collection can be used, too. Diagnostic accuracy of these procedures is suboptimal, and some procedural mistakes may account for it. METHODS AND RESULTS: The video shows how to properly collect secretions from the upper airways for nonserologic diagnosis of COVID-19 by nasopharyngeal swab (NPS), oropharyngeal swab (OPS), and deep saliva collection after throat-cleaning maneuver, all performed under videoendoscopic view by a trained ENT examiner. CONCLUSIONS: We recommend to perform NPS after elevation of the tip of the nose in order to reduce the risk of contamination from the nasal vestible, and to let it flow over the floor of the nasal cavity in parallel to the hard palate in order to reach the nasopharynx. Then the tip of the swab should be left in place for few seconds, and then rotated in order to achieve the largest absorption of nasopharyngeal secretions. Regards OPS, gentle anterior tongue depression should be used to avoid swab contamination from the oral cavity during collection of secretions from the posterior pharyngeal wall. These procedural tricks would enhance diagnostic reliability.","Head Neck","Torretta, Sara","Zuccotti, Gianvincenzo","Cristofaro, Valentina","Ettori, Jacopo","Solimeno, Lorenzo","Battilocchi, Ludovica","D'Onghia, Alessandra","Pignataro, Lorenzo","Capaccio, Pasquale","32441380"],"abstract":["BACKGROUND: Diagnosis of Severe Acute Respiratory Coranavirus-2 (SARS-CoV-2) infection is currently based on real-time PCR (RT-PCR) performed on either nasopharyngeal (NPS) or oropharyngeal (OPS) swabs; saliva specimen collection can be used, too. Diagnostic accuracy of these procedures is suboptimal, and some procedural mistakes may account for it. METHODS AND RESULTS: The video shows how to properly collect secretions from the upper airways for nonserologic diagnosis of COVID-19 by nasopharyngeal swab (NPS), oropharyngeal swab (OPS), and deep saliva collection after throat-cleaning maneuver, all performed under videoendoscopic view by a trained ENT examiner. CONCLUSIONS: We recommend to perform NPS after elevation of the tip of the nose in order to reduce the risk of contamination from the nasal vestible, and to let it flow over the floor of the nasal cavity in parallel to the hard palate in order to reach the nasopharynx. Then the tip of the swab should be left in place for few seconds, and then rotated in order to achieve the largest absorption of nasopharyngeal secretions. Regards OPS, gentle anterior tongue depression should be used to avoid swab contamination from the oral cavity during collection of secretions from the posterior pharyngeal wall. These procedural tricks would enhance diagnostic reliability."],"journal":"Head Neck","authors":["Torretta, Sara","Zuccotti, Gianvincenzo","Cristofaro, Valentina","Ettori, Jacopo","Solimeno, Lorenzo","Battilocchi, Ludovica","D'Onghia, Alessandra","Pignataro, Lorenzo","Capaccio, Pasquale"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441380","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26270","locations":["swab"],"topics":["Diagnosis"],"weight":1,"_version_":1667523504823599105,"score":147.75446},{"pmid":32380382,"pmcid":"PMC7187880","title":"Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays.","text":["Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays.","In response to the COVID-19 pandemic, commercial molecular assays for SARS-CoV-2 testing have been rapidly developed and broadly deployed in laboratories worldwide. Although these assays have been reported to correlate well, we sought to compare the Xpert(R) Xpress SARS-CoV-2 to the cobas(R) SARS-CoV-2 or the Lightmix(R) Modular SARS and Wuhan CoV E-gene assay for nasopharyngeal (NP) swabs with low levels of SARS-CoV-2 RNA. Thirty-seven NP swabs were studied, including 10 samples with a moderate cycle threshold (Ct) between 30-33.9, and 22 with Ct>/=34, and 5 negative for SARS-CoV-2. Overall concordance on initial comparison was 86.5 % (32/37), which was 100 % concordance for samples with Ct values ranging between 30-33.9. Discordance amongst samples showing a Ct >/=34 was 22.7 % (5/22). Endpoint value analysis on the Xpress SARS-CoV-2 within the discordant samples noted two with an endpoint value >5, which were detected by the cobas(R) or Lightmix(R). Testing of SARS-CoV-2 on the three commercial assays was comparable for NP swabs with moderate Ct values, while high Ct values were less concordant. Importantly, analysis of Xpert(R) endpoint values improved interpretation of discrepant results.","J Clin Virol","Lowe, Christopher F","Matic, Nancy","Ritchie, Gordon","Lawson, Tanya","Stefanovic, Aleksandra","Champagne, Sylvie","Leung, Victor","Romney, Marc G","32380382"],"abstract":["In response to the COVID-19 pandemic, commercial molecular assays for SARS-CoV-2 testing have been rapidly developed and broadly deployed in laboratories worldwide. Although these assays have been reported to correlate well, we sought to compare the Xpert(R) Xpress SARS-CoV-2 to the cobas(R) SARS-CoV-2 or the Lightmix(R) Modular SARS and Wuhan CoV E-gene assay for nasopharyngeal (NP) swabs with low levels of SARS-CoV-2 RNA. Thirty-seven NP swabs were studied, including 10 samples with a moderate cycle threshold (Ct) between 30-33.9, and 22 with Ct>/=34, and 5 negative for SARS-CoV-2. Overall concordance on initial comparison was 86.5 % (32/37), which was 100 % concordance for samples with Ct values ranging between 30-33.9. Discordance amongst samples showing a Ct >/=34 was 22.7 % (5/22). Endpoint value analysis on the Xpress SARS-CoV-2 within the discordant samples noted two with an endpoint value >5, which were detected by the cobas(R) or Lightmix(R). Testing of SARS-CoV-2 on the three commercial assays was comparable for NP swabs with moderate Ct values, while high Ct values were less concordant. Importantly, analysis of Xpert(R) endpoint values improved interpretation of discrepant results."],"journal":"J Clin Virol","authors":["Lowe, Christopher F","Matic, Nancy","Ritchie, Gordon","Lawson, Tanya","Stefanovic, Aleksandra","Champagne, Sylvie","Leung, Victor","Romney, Marc G"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380382","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jcv.2020.104387","keywords":["covid-19","cobas","endpoint values","xpert"],"topics":["Diagnosis"],"weight":1,"_version_":1666596532354285570,"score":147.45937}]}